"Scientists Explore Potential Reversal of Male Pattern Baldness"
HairClone, a company focused on developing a cell therapy treatment for male pattern baldness, aims to reverse the miniaturization process by banking youthful follicles and cloning and multiplying dermal papilla cells in the laboratory. The hope is that injecting these cells back into the scalp will plumpen the follicles and restore hair to a more youthful state. While the efficacy of the approach has not yet been established in a clinical trial, HairClone is working towards manufacturing cells to clinical standards and hopes to offer the treatment on an experimental basis within the next 12-18 months. The ability to predict a man's eventual hairline through genetic markers hidden inside dermal papilla cells may also help inform treatment choices in the future.